Researchers are launching a new study to investigate whether GLP-1 drugs, already approved for type 2 diabetes and obesity, could help treat long COVID symptoms. The medications are currently being ...
A large-scale global study has identified genetic variants that are risk factors for long COVID, a discovery that helps researchers better understand the biological systems involving the disease and ...
Turns out, Chronic Fatigue Syndrome (CFS) and long COVID have a few things in common. For one, they're notoriously tricky to diagnose. So when researchers said they developed a blood test that may be ...
A study suggests vitamin D may reduce long COVID symptoms at 8 weeks, although larger trials are needed to confirm benefits ...
According to a study published in JAMA Network Open, 8.3% of U.S. adults — equivalent to about 21.3 million people — reported ...
The first time Dr. Anita Chopra had a long COVID patient, she cried. It was two years after the pandemic, she said, when the once-healthy patient described symptoms of weakness, chronic fatigue and ...
Heterogeneous long COVID definitions across CDC, NASEM, and studies create downstream effects on diagnosis thresholds, treatment pathways, and outcome measurement, undermining equity and research ...
Long COVID can linger long after the acute infection ends. People report fatigue, brain fog, dizziness, and poor sleep. Many struggle to work or manage basic chores. Some crash after small efforts, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results